Pharma Strategy: Loss of Exclusivity (LOE) – PowerPoint PPT Template

HEALTHCARE PPT TEMPLATE DESCRIPTION

Editor Summary Pharma Strategy: Loss of Exclusivity (LOE) is a 25-slide PowerPoint by LearnPPT Consulting that provides a strategic framework and practical templates to manage patent expirations. Read more Covers 3 LOE strategy options (preserve brand equity, develop OTC, launch generics), a 3-phase planning timeline (pre-, peri-, post-LOE), and 5 deliverable templates including a Brand Affinity checklist, LOE planning timeline, strategy development and performance-tracking templates. Sold as a digital download on Flevy with immediate digital download. Used by pharmaceutical executives, marketing, product managers, and business development teams for LOE planning.

Use this deck when a pharmaceutical product is approaching patent expiry and teams must define actions to protect revenue, patient loyalty, and market share.

  Pharmaceutical executives running scenario planning to choose between preserving brand equity, OTC conversion, or generic launch using the Brand Affinity checklist.
  Marketing and sales teams designing patient acquisition and retention programs tied to an LOE timeline and marketing program templates.
  Product managers building a lifecycle execution plan that aligns pre-, peri-, and post-LOE activities with launch milestones.
  Business development leads evaluating market-entry options and regulatory impacts for OTC or generic strategies.

The presentation’s 3-phase timeline and checklist-driven approach reflect structured lifecycle planning used in pharmaceutical strategy engagements.

Read Presentation Deep Dive

Explore Slides inside the Deck:

Strategies for Launching Generic Pharmaceuticals Strategies for Maximizing Brand Value Post-Patent Strategic Timeline for Managing Loss of Exclusivity

Expiration of a drug patent means end of the branded drug value and revenue stream for a majority of pharmaceutical firms. This loss of exclusivity (LOE) puts to risk a huge amount of money in global pharmaceutical sales.

LOE certainly brings about a steep decline in a drug sales. A brand's unit share declines to about 16% by the time generics arrive and play in the market for a year. However, this is not a "game over" scenario.

This deck discusses 3 key strategies to preserve value for the brands after patent expiration:

1. Preserve Brand Equity and Patient Loyalty
2. Develop an Over-the-Counter (OTC) Version
3. Launch a Generic Version

No matter which LOE strategy a company selects to maintain product revenue, early action and execution is critical.

LOE is part of the different phases of a product's lifecycle and should be strategically thought out and managed. The presentation also highlights other avenues to tap revenue opportunities besides extending a drug's patent life through reformulations and introducing new indications.

The slide deck also includes some slide templates for you to use in your own business presentations.

The PPT provides a comprehensive guide on managing the critical phase of Loss of Exclusivity (LOE) in the pharmaceutical industry. It emphasizes the importance of early planning and execution to mitigate the impact on revenue streams. The strategies outlined are not just theoretical, but are backed by practical templates and checklists to facilitate implementation.

The presentation also delves into the nuances of brand affinity and market dynamics, offering insights into how these factors influence the choice of LOE strategy. It includes a detailed timeline for planning and executing LOE strategies, ensuring that companies can navigate this challenging phase with precision and foresight. This resource is indispensable for pharmaceutical executives aiming to sustain brand value and revenue post-patent expiry.

Explore Slides inside the Deck: